pharma news today obesity drugs glp-1 Drugmaker Eli Lilly announced that the FDA approved its daily pill, which will be marketed under the name Foundayo, to treat obesity. ABC News' Youri Benadjaoud reports. https://abcnewslive.visitlink.me/pYGbNh How are GLP-1 drugs impacting

FOXO4-DRI Peptide Vial FOXO4-DRI is a synthetic peptide designed to target and eradicate senescent cells

It is only by this approach that clinicians may remain in the position of trying to afford their optimum available best quality service for improving life with high quality for patients with disorders of the thyroid gland (Knight et al

Breastfeeding After giving birth, it often takes several months to get a period again, and even longer before your periods become normal

Iodine deficiency can result in nodular goiter, where thyroid antigens are secreted from the abnormal gland, causing anti-thyroid antibodies to be present in the circulation

The meeting offers a glimpse into how the second Trump administrations drug regulators could respond to the rapidly expanding popularity of peptides that have not been FDA-approved